COVID-19 Antiviral Pill 89% Effective In High Risk Cases – Pfizer
The Pfizer drug, known as a protease inhibitor, is designed to block an enzyme the virus needs in order to multiply. EKO HOT BLOG reports that an experimental pill to treat COVID-19 developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest. The … Read more